Investigator Name: Darren Hodgson
Organization: Oncology R&D
Function: Executive Director Clinical Biomarker Development
Role in GUIDE.MRD (brief description): AstraZeneca is contributing funding and expertise in ctDNA assay development and clinical implementation.
Expectation of GUIDE.MRD (brief description): AstraZeneca is delighted to participate in GUIDE.MRD and expects the project to reduce the time taken for the evaluation of MRD tests and the subsequent clinical adoption of those that benefit patients.
E-mail address: firstname.lastname@example.org